November 06, 2024 05:20 (IST)
Optimus submits interim result of phase III clinical trials for Molnupiravir capsules
Hyderabad/UNI: Optimus Pharma on Wednesday said that it has submitted the interim result of phase III clinical trials for orally administered Molnupiravir capsules on patients with mild covid infection.
Latest Headlines